June 17, 2014
Moderna Named to CNBC Disruptor 50 List
June 12, 2014
Moderna Announces Expansion to New Facility in Kendall Square
May 21, 2014
Moderna Forms Technology Advisory Board to Provide Expertise for the Company’s GMP Manufacturing Strategy
March 06, 2014
Moderna Appoints Biotechnology Investment Banking Veteran Lorence Kim as Chief Financial Officer
February 19, 2014
Massachusetts Life Sciences Center Awards Tax Incentives to 33 Companies (PDF File)
January 14, 2014
Moderna Launches Onkaido Therapeutics to Focus on the Development of mRNA Therapeutics™ in Oncology with $20 Million Capital Commitment
January 13, 2014
Alexion Pharmaceuticals and Moderna Therapeutics Announce Exclusive Strategic Agreement to Develop Messenger RNA Therapeutics™ for Rare Diseases
January 06, 2014
Moderna Therapeutics to Present at 32nd Annual J.P. Morgan Healthcare Conference
December 17, 2013
Moderna Therapeutics Appoints Theo Melas-Kyriazi to Board of Directors
November 20, 2013
Moderna Closes New Financing Round Raising $110M to Develop Messenger RNA Therapeutics™

Pages